News
Direct Biologics Granted Expanded Access by FDA for ExoFlo...
Direct Biologics, LLC, announced that the FDA has granted expanded access for ExoFlo in the treatment of patients with COVID-19 associated acute respiratory distress syndrome...
Clinical Trials
Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances...
AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside the...
News
Gilead Sciences signs joint procurement agreement with the European...
Gilead Sciences and the EC signed a joint procurement agreement (JPA) that will enable rapid and equitable access to Veklury® (remdesivir), the first antiviral drug...
News
Regeneron’s REGN-COV2 antibody cocktail reduced viral levels and improved...
Regeneron Pharmaceuticals, Inc. announced the first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 showing it...
News
BryoLogyx Announces Completion of World’s First GMP Synthesis of...
BryoLogyx, Inc., announced that it has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good Manufacturing Practice (GMP) regulations. Bryostatin-1 is the company’s lead...
Clinical Trials
Johnson & Johnson Temporarily Pauses All Dosing in Our...
At Johnson & Johnson, there is no greater priority than the safety and well being of the people we serve every day around the world....
News
New Zealand signs deal with Pfizer, BioNTech for Covid-19...
The New Zealand government signed a deal on Monday to buy 1.5 million COVID-19 vaccines from Pfizer Inc and Germany’s BioNTech, with delivery potentially as...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.